Monoclonal Antibody Drugs:
One of the newest drugs developed is monoclonal antibodies that target and clear amyloid proteins from the body. These drugs are designed to attach themselves to the amyloid protein, flagging it for destruction by the immune system.
Chemotherapy is another treatment option available for amyloidosis patients, which involves using drugs to kill cancerous cells that cause the accumulation of amyloid proteins. However, the treatment should be provided by an experienced oncologist, as certain chemotherapy drugs can augment the symptoms.
Stem Cell Transplantation:
This is another approach that has shown great promise in treating amyloidosis patients. This procedure involves replacing damaged or diseased stem cells with healthy ones. This enables the immune system to fight the amyloid accumulation and repair the damage caused to organs.
Gene therapy involves altering genes that produce mutated amyloid proteins, thereby preventing their formation and ensuing build-up in the body's tissues. This promising treatment option is experimental, although recent studies have shown promising results in mice models.
Combination therapy involves using two or more drugs in synergy to target amyloid proteins, destroying the mutant clones and preventing the development of new ones.
Despite the rarity of amyloidosis, researchers worldwide are making significant strides in the understanding and treatment of this disease. Emerging therapies, such as monoclonal antibody drugs, stem cell transplantation, gene therapy, and Combination therapy, provide hope for treating and curing patients suffering from the disease. The advancement in amyloidosis treatment is a hope for patients and their families; the industry is witnessing the development of novel approaches to tackle the complexity of this disease and help find an eventual cure.